loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    End Use API - CAS 114772-55-3 manufacturers and suppliers on PharmaCompass

    Client Email Product
    Menu

    CAS 114772-55-3

    Manufacturers/Suppliers

    MARKET PLACE

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Sanpra Synthesis (1)

    02 Smilax Laboratories Limited (1)

    03 Zhejiang Huahai Pharmaceutical Co., Ltd. (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    Product-page Product Main Page
    price-trend Ask Us

    Sanpra Synthesis

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Cyanolosartan

      PDF Supplier PDF
      URL Supplier Web Content
      114772-55-3
      Losartan Potassium
      Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business backgro...
      Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business background, it is aptly positioned for APIs and intermediates manufacturing and outsourcing for the global market. We also undertake custom synthesis and contract manufacturing. Setting up multiple c GMP-manufacturing facility and world-class R&D center located in Vizag APSEZ De-notified area with well connected to road, rail, and air enabling cargo movement to the nearest transport facility in commercial production from January 2020.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Smilax Laboratories Limited

      Contact Supplier
      • EDQM
      • WHO-GMP
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      2-(4-{[2-Butyl-4-chloro-5- (hydroxymethyl)imidazolyl]me...

      PDF Supplier PDF
      URL Supplier Web Content
      114772-55-3
      Losartan Potassium
      Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
      Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Zhejiang Huahai Pharmaceutical Co.,...

      Contact Supplier
      • FDA
      • EDQM
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      2-butyl-4-chloro-1-[(2'-cyanobiphenyl-4-yl)methyl]-5-hy...

      PDF Supplier PDF
      URL Supplier Web Content
      114772-55-3
      Losartan Potassium
      Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
      Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Post Enquiry
      POST ENQUIRY